search
Home > San Antonio jobs > San Antonio focus group/studies

Posted: Saturday, September 16, 2017 11:03 AM

Paid Clinical Trials in San Antonio, Texas

Severe Rosacea Study

Do you have severe rosacea?

Did you know many people who have severe rosacea actually think they have severe acne?

If you know you have severe rosacea or are currently experiencing what you think is severe acne, you may actually have severe rosacea and may qualify for a research study.

To qualify you must:

  • be an adult
  • currently have severe rosacea - a persistent red face with spider-like veins
  • and have 30 or more acne-like bumps on your face.

Qualified participants will receive investigational study medication at no cost and may receive compensation for your time.

Call Progressive Clinical Research in San Antonio (210) 614-5557

At Progressive Clinical Research in San Antonio, TX, participants receive free study-related medical care and procedures. The medical study drug is provided free of charge and participants may be paid for their time and travel. No insurance is required.

Our organization is based on teamwork dedicated to exceptional patient care and to the performance of quality pharmaceutical research. Progressive Clinical Research is an independent, multispecialty research facility located in the heart of the South Texas Medical Center. Our physicians and coordinators have been involved in clinical research studies in San Antonio for over fifteen years.

Click here to sign up today or call us at (210) 614-5557 during business hours.

For information about compensation or payment for specific studies, please contact us.

Get started here

Progressive Clinical Research

Progressive Clinical Research
1973 NW Loop 410, Suite #106
San Antonio, TX, 78213
Phone: (210) 614-5557
Mon - Thurs 8am to 5pm
Friday 8am-4pm
www.progclin.com

1973 NW Loop 410, Suite #106, 78213    google map | yahoo map

• Location: San Antonio

• Post ID: 31376367 sanantonio
sanantonio.backpage.com is an interactive computer service that enables access by multiple users and should not be treated as the publisher or speaker of any information provided by another information content provider. © 2017 backpage.com